Aura Biosciences Inc (AURA)
US Market

Aura Biosciences Inc (AURA) Income Statement


Aura Biosciences Inc Income Statement

Last quarter (Q3 2023), Aura Biosciences Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Aura Biosciences Inc's net income was $-18.51M. See Aura Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 0.00$ 0.00
Cost of Revenue
Gross Profit
Operating Expense
$ 42.59M$ -60.30M$ -35.25M$ 22.21M$ 24.14M
Operating Income
$ -77.82M$ -60.30M$ -35.25M$ -22.21M$ -24.14M
Net Non Operating Interest Income Expense
$ 3.99M-$ -46.19M$ -3.00K$ -5.00K
Other Income Expense
$ -32.02M$ -1.53M$ 3.00K$ 3.00K$ -55.00K
Pretax Income
$ -28.63M$ -58.76M$ -81.43M$ -22.21M$ -24.20M
Tax Provision
Earnings From Equity Interest Net Of Tax
$ 28.74M----
Net Income Common Stockholders
$ -28.63M$ -58.76M$ -81.43M$ -30.13M$ -24.20M
Basic EPS
$ -2.38$ -1.96$ -8.95$ -1.60$ -1.74
Diluted EPS
$ -1.94$ -1.96$ -8.95$ -1.60$ -1.74
Basic Average Shares
$ 143.76M$ 29.94M$ 5.16M$ 13.89M$ 13.89M
Diluted Average Shares
$ 143.76M$ 29.94M$ 5.16M$ 13.89M$ 13.89M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 42.59M$ -60.30M$ -35.25M$ 22.21M$ 24.14M
Net Income From Continuing And Discontinued Operation
$ -28.63M$ -58.76M$ -81.43M$ -22.21M$ -24.20M
Normalized Income
$ -14.62M--$ -22.21M$ -24.19M
Interest Expense
---$ 3.00K$ 5.00K
$ -28.63M$ -58.76M$ -81.43M$ -22.21M$ -24.20M
$ -9.17M$ -57.59M$ -80.60M$ -21.38M$ -23.69M
Currency in USD

Aura Biosciences Inc Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis